Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moritz Binder

Showing results (41-50 of 95) with videos related to

Pageof 10
Sort By:
Blood Cancer Journal|August 17, 2023
Long-term outcomes of allogeneic stem cell transplant in multiple myelomaWalker M Schmidt, Nirosha D Perera, Francis K Buadi, et al.
Leukemia|September 28, 2025
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysisSaurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, et al.
Leukemia|December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndromeKenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.
Haematologica|May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic responseMatthew J Rees, Susan Geyer, Binoy Yohannan, et al.
Blood Advances|June 25, 2026
Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System InvolvementAlexander Xiao, Saurabh S Zanwar, Yi Lin, et al.
British Journal of Haematology|February 16, 2019
Substratification of patients with newly diagnosed standard-risk multiple myelomaMoritz Binder, S Vincent Rajkumar, Rhett P Ketterling, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
American Journal of Hematology|January 2, 2023
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survivalCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Blood Cancer Journal|May 15, 2023
Conditional survival in multiple myeloma and impact of prognostic factors over timeNadine H Abdallah, Alexandra N Smith, Susan Geyer, et al.
Blood Cancer Journal|August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresisElham Askari, Angela Dispenzieri, Francis K Buadi, et al.
Pageof 10

Showing results (41-50 of 95) with videos related to

Sort By:
Pageof 10
Blood Cancer Journal|August 17, 2023
Long-term outcomes of allogeneic stem cell transplant in multiple myelomaWalker M Schmidt, Nirosha D Perera, Francis K Buadi, et al.
Leukemia|September 28, 2025
Refining PET-based response in extramedullary multiple myeloma using total lesion glycolysisSaurabh Zanwar, Gokce Belge Bilgin, Stephen M Broski, et al.
Leukemia|December 16, 2024
Capillary leak phenotype as a major cause of death in patients with POEMS syndromeKenzie Lee, Taxiarchis Kourelis, Marcella Tschautscher, et al.
Haematologica|May 22, 2025
Clonal plasma cell features in light-chain amyloidosis are associated with depth and timing of cardiac response independent of hematologic responseMatthew J Rees, Susan Geyer, Binoy Yohannan, et al.
Blood Advances|June 25, 2026
Clinical Course, Risk Factors, and Therapeutic Response in Multiple Myeloma with Central Nervous System InvolvementAlexander Xiao, Saurabh S Zanwar, Yi Lin, et al.
British Journal of Haematology|February 16, 2019
Substratification of patients with newly diagnosed standard-risk multiple myelomaMoritz Binder, S Vincent Rajkumar, Rhett P Ketterling, et al.
Blood Advances|April 12, 2022
Outcomes after biochemical or clinical progression in patients with multiple myelomaSarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, et al.
American Journal of Hematology|January 2, 2023
Thrombosis in multiple myeloma: Risk estimation by induction regimen and association with overall survivalCharalampos Charalampous, Utkarsh Goel, Prashant Kapoor, et al.
Blood Cancer Journal|May 15, 2023
Conditional survival in multiple myeloma and impact of prognostic factors over timeNadine H Abdallah, Alexandra N Smith, Susan Geyer, et al.
Blood Cancer Journal|August 7, 2025
Value of serum-free light chain measurements in response and progression assessment in multiple myeloma with monoclonal protein measurable by electrophoresisElham Askari, Angela Dispenzieri, Francis K Buadi, et al.
Pageof 10